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Invasive Species Control and Resolution
of Wildlife Damage Conflicts:
A Framework for Chemical
and Genetically Based Management
Methods
Larry Clark, John Eisemann, John Godwin, Katherine E. Horak, Kevin Oh,
Jeanette O’Hare, Antoinette Piaggio, Kimberley Pepin, and Emily Ruell

Abstract Vertebrate wildlife damage management relates to developing and
employing methods to mitigate against damage caused by wildlife in the areas of
food production, property damage, and animal or human health and safety. Of the
many management tools available, chemical methods (e.g., toxicants) draw the
most attention owing to issues related to environmental burden, species specificity,
and humaneness. Research and development focusing on RNA interference and
gene drives may be able to address the technical aspects of performance goals.
However, there remain many questions about regulation, environmental risk, and
societal acceptance for these emerging biological technologies. Here we focus on
the development and use of these biological technologies for use in vertebrate pest
management and conservation (e.g., management of wildlife diseases). We then
discuss the regulatory framework and challenges these technologies present and
conclude with a discussion on factors to consider for enabling these technologies for
pest management and conservation applications under a commercially applied
framework.
Keywords Gene drive · Gene silencing · RNAi · Wildlife · Regulation · Product
development · Pest control
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Introduction
The field of vertebrate wildlife damage management relates to developing and
employing methods to mitigate damage caused by wildlife in the areas of food production, property damage, and animal or human health and safety (Conover 2001).
The methods used to resolve such conflicts include the use of physical devices (e.g.,
traps, sonic or visual scaring methods), chemical methods (e.g., reproductive inhibitors, repellents, toxicants), direct lethal control (e.g., culling), and alterations to the
landscape (e.g., habitat manipulation). Unlike other areas of wildlife management
that involve natural resource protection for conservation or sustainable consumptive
and nonconsumptive recreational use, wildlife damage management seeks to alter
animal behavior or circumstances to prevent damage to human activity or interests
that may be caused by wildlife and hence involve more direct and interactive
approaches to management.
For the most part, the technologies and methods used by wildlife damage managers have long histories (Reidinger Jr and Miller 2013). Among the many management tools, chemical toxicants have proven to be both effective and controversial
(Eason et al. 2010). For the most part, criticism has focused on five areas: effectiveness, need and/or alternatives, humaneness, nontarget effects, and environmental
burden. Thus, imperative for managers in the development of new technologies is to
consider developing methods that provide for sustainable agricultural production
and natural resource stewardship within a social license framework.
If the use of vertebrate pesticides is required, then it is desirable for them to be
species-specific, thus eliminating direct nontarget risks. The pesticide should also
reduce environmental and ecological burden. That is to say, once the target effect is
achieved, diffusion into the environment and amplification through the food chain
should not occur, thus eliminating indirect nontarget effects. The mode of action for
the pesticide should reduce animal awareness to pain and have a short time to death,
both traits that contribute to current standards for humane death (Underwood et al.
2013). As the science evolves and the options for mode of action and nature of the
pesticide broaden, there should be regulatory clarity from authorizing agencies and
guidance to users in the form of approved labeling and licensing of products.
Because the research, development, and regulatory processes are complex and not
necessarily familiar to wildlife damage managers, it is vital that communication
among the developing partners is well founded and follows an orderly process so
that formulation, effectiveness testing, technology transfer, production, delivery,
and scalability result in a cost-effective product that is easily applied on a landscape
scale. Finally, and perhaps most importantly, it is imperative that a communication
and engagement plan is developed for users and the community. It does little good
to develop an expensive tool only to have it fail because of unanticipated or unaddressed concerns within the human social and political framework.
Traditional strategies to control pest species include biological (use of predators,
crop rotation), mechanical (physical removal), and chemical (toxicants, repellents).
Biological and mechanical methods are often chosen to limit the use of chemicals
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as a means to reduce impacts to the environment and nontarget species (Damalas
and Eleftherohorinos 2011; Kogan 1998; Witmer 2007). Yet chemical methods may
be favored because pest population control often occurs more quickly and with less
monetary investment than when other techniques are used. More recently, research
has focused on development of biological pesticides that combine target specificity,
humaneness, and low environmental burden with the response and cost efficiencies
of traditional chemical applications, such as gene drive technology and RNA interference. These technologies hold the promise to address the objectives identified
above and perhaps decrease the reliance on use of chemical pesticides.
Here we focus on the development and use of two technologies that hold promise
as tools for vertebrate wildlife management and conservation: gene silencing
through RNA interference and gene drives.

Gene Silencing
Interest in RNA interference (RNAi) as a tool for basic research and for the treatment of diseases started with its discovery in the 1990s. Since then, the utility of
RNAi as a means to control pest species has become increasingly popular. Successes
in the development of RNAi toxicants to control insects and novel methods using
plants as a means to deliver RNAi to feeding insects have expanded initial expectations of the applications of this technology. In 2017, the US Environmental
Protection Agency (EPA) registered the first RNAi-based insecticide for the control
of Western corn rootworm (Diabrotica virgifera virgifera). This EPA registration
ushers in a new era in toxicant development with the ability to design toxicants that
are species-specific alleviating concerns of risks to nontarget species, and following
the promise shown for insect control, there is increasing interest for use of this technology for applications in vertebrate pest management.
RNA interference (RNAi) is a fundamental cellular process that controls what
genes are turned on and off by determining what proteins are synthesized from the
messenger RNA (mRNA) messages in the cytoplasm. RNAi shows promise as a
class of species-specific toxicants because RNAi molecules, by design, bind specifically to a single mRNA triggering its destruction. The instructions for protein synthesis travel from DNA in the nucleus to the cytoplasm by messenger RNA (mRNA)
(Crick 1970). These single-stranded mRNA molecules are composed of unique
sequences of nucleotides that code for specific proteins.
The first indication that translation from mRNA to protein may be influenced by
exogenous RNA sequences came when Jorgensen (1998) attempted to increase the
purple pigment in petunia flowers by injecting extra copies of the pigment gene into
the plant. The result of these injections was not flowers that were more purple, but
surprisingly yielded either two-toned or totally white flowers (Fire et al. 1998;
Jorgensen et al. 1998; Napoli et al. 1990). Jorgensen termed this phenomenon “co-
suppression.” This was the first experimental demonstration of the process now
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called RNA interference for which Andrew Z. Fire and Craig C. Mello were awarded
a Nobel Prize in 2006.
RNAi is dependent on the inherent protective pathway within cells that degrades
mRNA. Double-stranded RNA (dsRNA) binds to a protein called Dicer that cleaves
the dsRNA into smaller fragments that are then integrated into the RNA-induced
silencing complex, RISC (Liu et al. 2004; Tang 2005; Zhang et al. 2004). The RISC
complex then separates the short dsRNA fragments into single-stranded segments,
one of which is shuttled to and binds the matching mRNA sequencing that was
transcribed from DNA. The complex formed by the RISC (with fragment of the
initial dsRNA) and the mRNA then cleaves and degrades the mRNA guided by
properties of the fragment of the initial dsRNA (Khvorova et al. 2003; Schwarz
et al. 2003). The gene for which the mRNA is coded is, therefore, not synthesized,
and the gene is “silenced.” Since its discovery, this sequence-specific gene silencing
has shown great promise as both a research tool and in the treatment of diseases
(Lares et al. 2010). More recently, interest in using RNAi as a means to control pest
species has become increasingly popular; however, to date, this interest has been
focused on insect pests (Baum and Roberts 2014; Burand and Hunter 2013; Mamta
and Rajam 2017; Niu et al. 2018; Zotti et al. 2018).

Gene Silencing: Pest Control and Risk
The success of RNAi as a “chemical” means to control pest species depends on
multiple factors. Though the RNAi pathways are inherently present in cells, introduction of exogenous RNAi is still recognized as nonself and therefore can elicit an
immune response and subsequent release of inflammatory cytokines (Alexopoulou
et al. 2001; Heil et al. 2004). Responses such as these are called off-target effects as
they are not related to the desired physiological response from the RNAi-induced
gene silencing. Significant effort is made during the design of RNAi molecules to
reduce off-target effects and minimize immune response (Schwarz et al. 2003). Off-
target effects are a concern in nontarget species as they can occur even if the target
sequence of the RNAi is not present in the nontarget animal. Nontarget species will
not be affected by the directed silencing of specific genes, but the RNAi must not
elicit an immune response in nontarget species. If successful, one of the benefits of
RNAi over traditional chemical toxicants is its species specificity. Comparisons
between gene sequences in target and nontarget species are done to determine
regions of the genes that are the most different. RNAi molecules are then designed
to those regions. These sequence differences result in a mismatch between the RNA
incorporated in the RISC complex and the mRNA in the cytoplasm, blocking degradation of the mRNA (Amarzguioui et al. 2003). It is possible to design RNAi
molecules that differ from target mRNA by a single nucleotide and therefore do not
bind; purine/purine mismatches offer the highest level of discrimination (Schwarz
et al. 2006). Nucleotide mismatches in different regions of the RNAi also affect
specificity, with the last two nucleotides of the same types of RNAi molecules not
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contributing to binding to the mRNA (Elbashir et al. 2001), so mismatches in those
regions do not affect binding and subsequent mRNA degradation. The requirement
of exact matching of RNAi and target mRNA sequences places a burden on the
development of RNAi-based chemical toxicants, as genes of wildlife species are
often not sequenced. In addition, ensuring the target sequence in conserved diverse
animal populations that are geographically separated needs to be done before
sequences are registered for use as toxicants.
Using RNAi as a means to control pest populations is contingent on delivery of
the nucleotide sequence to both the target species and the desired location in the
organism. Toxicant baits containing RNAi face the same requirements as traditional
chemical toxicant baits of attractiveness to target species and stability in harsh environmental conditions. This is a challenge as RNAi is, by its nature, unstable.
Modifications to the RNAi sequences, such as the addition of 2’-O-methylpurines
or 2-fluoropyrimidines, have been shown to increase stability without decreasing
effectiveness (Czauderna et al. 2003). Once the pest species consumes the RNAi
bait, getting the RNAi to the target tissue in appropriate concentration becomes the
next hurdle. RNAi baits will be formulated for oral delivery meaning the RNAi will
have to survive the extreme conditions of the gastrointestinal tract before absorption
into the systemic circulation. Lipid nanoparticle carriers have shown promise in
protecting the RNAi from degradation at low digestive pH (Ball et al. 2018). Once
in systemic circulation, the RNAi must get to the target location. This can be
achieved through the addition of cell-type-specific ligands, antibodies, or receptors
on the carrier molecule. Uptake of the RNAi by target cells can be facilitated by the
use of cell-penetrating peptides, nanoparticles, and polymer-based delivery systems
(Ahmadzada et al. 2018; Avila et al. 2016; Singh et al. 2018a, b). Once inside the
cell, the RNAi will then silence the target gene by directed destruction of the mRNA.
There are numerous obstacles for delivery of an RNAi toxicant for use in vertebrate pests, from the development of the oral bait to shuttling the RNAi to the target
tissue. However, research from human drug development and successes in the fields
of insect control lay the foundation for vertebrate RNAi toxicant development and
wildlife disease treatments in the field.

Gene Drives
Pest control technologies using RNAi have the potential to come to use sooner and
under a clear regulatory framework (see below). Such technologies will also most
likely be applied similar to traditional chemical pesticides. However, gene drive
technologies hold the promise of being self-sustaining once released, thus eliminating the need for constant reapplication. It is this feature which is both appealing
from an economic logistical perspective and warrants caution from an environmental risk perspective.
It is not difficult to find popular news stories about the promise and potential
catastrophe that could be realized through the application of clustered regularly
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interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins
for genome editing and DNA. CRISPR-Cas systems have been identified from bacteria and archaea and provide immunity to ward off bacteriophages (Barrangou
2015). When harnessed for genome editing, the system has been shown to provide
targeted, sequence-specific cleavage of double-stranded DNA (Mali et al. 2013;
Jiang et al. 2013). This is accomplished through the precise delivery of endonuclease enzymes by synthetic single-guide RNA (sgRNA) that are engineered to bind
only to specific target sequences within the genome. These DNA cleavages will then
be repaired by the targeted genome through either homology-directed repair (HDR)
or nonhomologous end joining (NHEJ). HDR repairs with a homologue piece of
DNA, whereas NHEJ directly ligates the cleaved pieces of DNA and thus can lead
to a loss of nucleotides and other potential errors. With an engineered template, the
HDR process will repair the nicked DNA with a synthetic portion of DNA on both
DNA strands (Mali et al. 2013; Alphey 2014; Doudna and Charpentier 2014). Thus,
through the CRISPR-Cas system, double-stranded DNA can be cleaved at a targeted
site and repaired with a synthetic piece of DNA, which can then be copied in the
organism through regular genomic copying. Application of this technology has been
coined “synthetic biology,” and its utility has been realized in the pharmaceutical
and agricultural production already (Carlson 2010; Church and Regis 2012; Doudna
and Charpentier 2014; Gantz et al. 2015; Lander 2016; Hussain et al. 2018).
Because gene drive applications would not require constant application in the
sense of traditional chemical pesticides or even RNAi, there is inherent appeal to
managers that the management tool will be self-sustaining, whether for pest management or for control of disease susceptibility for wildlife conservation purposes,
e.g., avian malaria for protection of birds or plague resistance for protection of
endangered species.

Gene Drives: Uses for Disease Mitigation
Disease control is typically accomplished by reductions in host or vector abundance, reduction of contact between hosts and pathogens, or increase in the refractoriness or resistance of hosts or vectors to infections (Sokolow et al. 2019).
Traditional techniques include host culling, pesticides for vector control, physical
barriers between hosts and vectors, vaccination to reduce transmission, or treatment
to reduce severity and transmission. All of these interventions can be expensive and
time-consuming and have variable levels of effectiveness depending on ecological
conditions. Pesticide application can present health risks to humans and domestic
animals through contamination of soil or water supplies. Genetic modification
(GM) techniques can be developed to target genes that could affect any of these
processes and have the potential to be cheaper and more effective and have lower
host or environmental burden. For example, GM approaches can be designed to
target specific isolates or strains of a bacterium, which is advantageous over antibiotics because the specificity allows “good” bacteria to be unaffected (Barrangou and
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Doudna 2016). Strain-specific editing of bacterial populations is particularly useful
in food biotechnology where CRISPR systems have been used to vaccinate industrial bacterial cultures against viruses or to engineer antibiotic resistance uptake or
probiotic cultures (Selle and Barrangou 2015a, b). Similarly, it was recently shown
that a CRISPR-Cas13a system could be used to engineer potato plants to be resistant to potato virus Y while having no effect on related viruses such as potato virus
A (Zhan et al. 2019). The ability to efficiently protect crops or livestock against
specific agricultural diseases could dramatically improve food security while reducing the ecological footprint of agriculture (Herman et al. 2019; Van Eenennaam and
Young 2014).
One of the most active areas of disease control research has been to create gene
drives that repress vector populations or make them refractory to pathogens that
cause human diseases such as dengue or malaria (Ferguson 2018; Shaw and
Catteruccia 2019). For example, Anopheles stephensi, a vector of the malaria parasite Plasmodium spp., has been successfully engineered to have much reduced vector competence relative to wild-type vector individuals (Gantz et al. 2015; Ito et al.
2002). More recently, it has been demonstrated that a CRISPR-Cas9 system for
delivery of a female sterility trait could spread to 100% prevalence in 7–11 generations in caged Anopheles mosquitoes (Kyrou et al. 2018). Similar results have been
obtained using other gene targets (Hammond et al. 2016), suggesting that there is
ample opportunity to choose a target that will be successful in a particular ecological context (Champer et al. 2016). While not yet realized, the ability to protect
livestock against specific diseases efficiently using CRISPR technology is on the
horizon (Conklin 2019; Lamas-Toranzo et al. 2017).

Gene Drives: Uses for Conservation
Invasive mammalian predators represent a major threat to biodiversity worldwide.
Doherty et al. (2016) estimated mammalian predators are responsible for the extinction of at least 142 vertebrate species since AD 1500 (58% of the total including 87
bird, 45 mammal, and 10 reptile species) and threaten another 596 species. The key
invasive vertebrate predator threats involve species from 13 mammalian families
including rodents, felids, canids, and mustelids with seven species/groups in particular accounting for the bulk of the documented impacts on birds, mammals, and
reptiles: cats, rodents, dogs, pigs, small Indian mongoose, red fox, and stoats. Of
these, cats and rodents including three species of rats (Rattus spp.) and house mice
(Mus musculus) have proven particularly damaging with island faunas being especially hard hit for several reasons. First, islands harbor a disproportionate share of
biodiversity. Despite representing approximately 5% of the Earth’s land area,
islands are home to 20% of described vertebrate species and approximately 40% of
threatened and endangered species (Tershy et al. 2015; Spatz et al. 2017). Second,
the populations of island endemic species are often much smaller and are therefore
typically more vulnerable. Lastly, these island species have often evolved with few
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or no predators and consequently lack adaptive antipredator defenses (Adler and
Levins 1994; Cuthbert et al. 2016).
Because islands are hot spots for both biodiversity and threatened and endangered species, managing threats in island ecosystems has also been a central focus
for both conservationists and managers. In addition, for logistical reasons, islands
represent isolated contained systems of limited geographic scale which will be critical for effective early phase testing and evaluation.
A major focus of efforts on islands has been eradication of invasive mammalian
predators, and the outcomes have been tremendously positive (Cuthbert et al. 2011;
Jones et al. 2016). Despite the significant conservation benefits realized through
traditional eradication approaches, primarily aerial broadcast of rodenticides when
targeting rats and mice, these methods have both significant drawbacks and some
fundamental limitations (Campbell et al. 2015, 2019). The drawbacks include high
fixed costs for operations (often in the millions of US dollars), nontarget species
exposure to toxicants, and animal welfare concerns for both target and nontarget
species (Mackay et al. 2007; Holmes et al. 2015). Failures and other rationales can
often lead to significant social and political opposition. Lastly and critically, applying toxicant-based methods is extremely challenging on islands with human inhabitants, which represent the majority of islands where invasive mammals threaten
biodiversity. Indeed, Campbell et al. (2019) estimate that fewer than 15% of islands
worldwide where invasive rodents threaten critically threatened or endangered species are amenable to rodenticide-based eradication approaches. New approaches are
clearly needed.
Genetic methods of pest control potentially offer a useful alternative to these
established approaches. Although engineered gene drives harnessing either natural
or synthetic drive mechanisms are still in the development phase, population modeling supports their potential effectiveness in reducing invasive mammal populations
(Backus and Gross 2016; Prowse et al. 2017, 2019; Sudweeks et al. 2019). As
detailed above, harnessing natural or synthetic selfish genetic elements in the form
of gene drives could provide options not burdened by many of the drawbacks of
rodenticide-based approaches. Specifically, genetic approaches could provide flexibility in financial models relative to the high fixed costs of rodenticide-based eradications, where operations typically must be conducted within short time windows.
Genetic approaches should also be species-specific, eliminating at least direct
effects on nontarget organisms. A gene drive approach would likely affect target
pest populations through either biasing offspring sex ratios or inducing infertility in
drive carriers, thereby leading to population reduction through natural attrition. This
could alleviate animal welfare concerns that arise from the mechanism of action of
toxicants currently. The species specificity of genetic approaches could facilitate
use on inhabited islands due to the reduced threat to humans, pets, and livestock.
However, use on inhabited islands could raise other concerns, including increased
potential for movement of gene drive carriers from the targeted island and introduction of resistant individuals onto an island from nontarget populations. These are
also new, unfamiliar, and as yet untested and unproven technologies, so a great deal
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of effort will need to be dedicated to engaging stakeholders and relevant publics in
order to decide if, when, and how these approaches should be employed.
If a gene drive approach is employed for biodiversity conservation on islands,
how is such an effort likely to proceed? While rats and cats represent more significant overall threats to biodiversity and have been discussed as potential target organisms for gene drive approaches (Moro et al. 2018), efforts to date have been focused
on establishing feasibility in the house mouse. The feasibility of synthetic gene
drive approaches has thus far only been demonstrated in insects and yeast (Gantz
and Bier 2015; Gantz et al. 2015; Hammond et al. 2016; DiCarlo et al. 2015). The
house mouse is the preeminent, most manipulable, and intensively studied mammalian genetic model organism with a rich knowledge base to support efforts to
affect sex determination and fertility in this species (Campbell et al. 2019). No
functional synthetic gene drive has yet been described for a vertebrate, and a recent
report suggests generating one could prove challenging (Grunwald et al. 2019).
Therefore, focusing on the most genetically tractable mammal is likely the best
approach as well as advancing the general knowledge base necessary to advance
efforts in other mammalian pest species should efforts in mice prove successful.
A number of factors including invasive species threaten terrestrial vertebrates
worldwide (Allan et al. 2019). The foregoing discussion focused on use of genetic
technologies on islands, which are favorable due to physical containment provided
by geographic isolation. There is discussion of employing these technologies in a
continental context and a recently launched effort to explore the potential of genetic
approaches for controlling cats in Australia. Feral cats and red foxes represent the
major current threat to Australia’s terrestrial mammal fauna (Woinarski et al. 2015),
and existing control strategies are not equal to this challenge. This has prompted
consideration of gene drive approaches for control of feral cats (Moro et al. 2018;
Kinnear 2018). Key knowledge gaps remain, and advances in understanding the
potential of gene drive approaches for cats and other species will likely depend on
progress in implementing these approaches in rodents first.

Gene Drives: Risk
There are several types of risk that must be considered in evaluating the potential
utility of different pest control methods, such as ecological, evolutionary, economic,
and ethical (Gould 2008). All methods of pest control share some risks in common
(Herman et al. 2019). For example, reduction of pest populations can have ecological consequences in terms of ecosystem maintenance or community ecology (Gould
2008). Likewise, pesticide or repellant application or GM organisms can have economic risks due to evolution of resistance by the pest or ecological risks through
negative impacts on nontarget species. Any pest control method can pose ethical
risks through negative effects on human health or belief systems. All types of risks
should be thoroughly evaluated before a new technology can be applied.
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For innovative pest control approaches, the first type of risk assessment pursuits
typically are: Will the method work to reduce pest populations? How can we make
it work most efficiently? How will it affect nontarget species or the ecosystem?
Research to answer these questions then ensues. However, for GM organisms, there
is an additional layer of complexity: what research directions are safe and ethical
(Collins 2018; Courtier-Orgogozo et al. 2017)? The concept of GMOs, even for
low-risk improvements to crop production, is not supported broadly in the human
population (Linnhoff et al. 2017). It is important that differences in belief systems
are thoroughly evaluated while defining research and technology directions for GM
organisms (Shinwari et al. 2017). Questions of safety and ethics also have been
hotly debated in related fields such as studying gain-of-function mutations for
potentially pandemic viruses (National Research Council 2015; Lipsitch 2018). The
rationale is that, without better safeguards in place, the risk of releasing a synthetically engineered strain that could overcome natural barriers in the fitness landscape
and cause widespread devastation is much greater than the potential benefits that
could be gained by understanding this strain’s pathology and epidemiological
dynamics. Similar concerns have arisen for GM pest control approaches, especially
those with gene drive delivery (Abbasi 2016), because with super-Mendelian inheritance, these GM methods present a high risk of uncontrolled spread of genes (Akbari
et al. 2015; Backus and Gross 2016; Dhole et al. 2018; Esvelt et al. 2014) that could
have devastating consequences on nontarget populations. Thus, the perceived ecological risk of GM methods is so high that stringent containment conditions must be
used even to study these methods in the laboratory (Benedict et al. 2018), and effects
of these methods must be very well understood before they can proceed to contained field trials. This poses a severe but necessary limitation on the rate at which
the technology should advance (Abbasi 2016).
Most of the literature applicable to wildlife focuses on the use of CRISPR-Cas
systems to produce a “gene drive” or to push a trait introduced into a wildlife population to fixation or near fixation by avoiding Mendelian inheritance through inheritance by all offspring (Champer et al. 2016). This approach has been applied to
some mosquito species that carry malaria that infects humans or Hawaiian birds and
is being tested in laboratory and field experiments (Alphey 2014; Gantz et al. 2015;
Hammond et al. 2016; Kyrou et al. 2018). In wildlife management, the application
of this approach would need to be demonstrated in vertebrate species. This is a large
technological leap from cells, insects, and even plants. However, the work of investigating the feasibility of CRISPR-Cas-mediated gene drives has begun in house
mice (Piaggio et al. 2017; Grunwald et al. 2019) and thus holds promise for the
control of invasive species and agricultural pests, which has been a promise of
genetic engineering for over a decade (Burt 2003; Gould 2008).
Given the potential for synthetic gene drives to propagate rapidly within populations, the development of safeguards to spatially and temporally limit spread to
nontarget organisms is a key technological challenge (Noble et al. 2018). Unlike
most chemical-based management methods, RNA-guided gene drives are vertically
transmitted, and thus, species-specificity is largely ensured by normal assortative
mating among conspecifics. However, in many cases, the potential ecological
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impacts of uncontrolled spread into wildlife populations outside of the treatment
area may present an unacceptable risk (Gould 2008).
A second major risk factor that is currently poorly understood is potential evolution of a gene drive system. History has shown over and over that strong selection
can repeatedly and predictably produce resistance in pest species – antimicrobial
resistance is a primary example. For traits that strongly influence fitness, mutations
that occur during propagation of a deleterious gene can rapidly predominate, especially if they confer a fitness advantage. This has recently been observed in laboratory experiments with fruit flies (Drosophila melanogaster) to examine the efficiency
of a CRISPR-Cas9 homing element for driving inheritance of a “Killer-Y chromosome” that results in all male offspring (KaramiNejadRanjbar et al. 2018). Here,
gene-drive-resistant mutations readily arose in the mothers by in-frame indel mutations in the recognition site of the guide RNA, and these drive-resistant alleles
strongly impacted efficiency of the drive system (KaramiNejadRanjbar et al. 2018),
posing a potential economic risk for use in the wild. However, evolution of resistance could also pose ecological risks, and these mechanisms remain largely unexplored. For example, the mechanism by which a drive evolves could reduce target
population specificity or even improve pest reproductive performance, thus increasing the risk to nontargets or other ecosystem impacts. Exploring the evolutionary
landscape of candidate gene drive mechanisms using experimental evolution and
loss-of-function mutational analyses in high containment settings are critical risk
assessment steps to take. Importantly, these experiments need to occur using the
specific target species and gene drive mechanisms of interest because specific evolutionary mechanisms can differ across systems.
In addition to experiments, risk assessment based on expert opinion (Beech et al.
2009) can help to prioritize risk factors to be investigated in more detail, thus
improving efficiency of risk assessment. Simulation models are another efficient
and safe approach to risk assessment. Simulation models can help guide the design
of experiments efficiently (Restif et al. 2012) and improve our understanding of
how different ecological and evolutionary processes interact to determine risk to
nontarget individuals (Edgington and Alphey 2018). Models can be especially useful in high-dimensional systems where it is infeasible to test all potential factors
empirically. While models are not a substitute for experimental data, they can predict which characteristics of a GM system might be safest and most efficient in a
given ecological context (Dhole et al. 2018; Gemmell et al. 2013), improving efficiency of experimental design for risk assessment studies. Recent modeling work
on examining the spread rates of gene drive systems in vertebrate pests shows that
homing rates are an important characteristic of low-risk gene drive systems that
confer high eradication probabilities of the pest species (Prowse et al. 2017). This
work emphasizes that understanding factors that affect successful homing is a critical avenue for empirical research (Prowse et al. 2017). To date, models of gene drive
systems have focused primarily on combined population genetic-dynamic models
of a two-deme or island-mainland system (Dhole et al. 2018; Edgington and Alphey
2018; Sudweeks et al. 2019). However, individual-level spatial processes due to
social structure or movement behavior, and mating structure, can have important
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consequences for structuring genetic variation in space, suggesting that these are
important future directions for models and experiments to explore.

Gene Drives: Risk Mitigation
Several molecular strategies have been proposed to limit gene drive spread including physical separation of gene drive components (“split drive”; DiCarlo et al. 2015)
or gene drives that only function above a certain population frequency threshold
(Buchman et al. 2018; Leftwich et al. 2018). Engineering the system such that there
is a marker gene could also be useful for monitoring containment (Beech et al.
2009). Less efficient drive systems will be easier to contain than highly efficient
systems (Dhole et al. 2018). Thus, a clear understanding of the potential spread rates
for particular drive mechanisms is crucial for evaluating containment risk (Dhole
et al. 2018). Containment risk in a target area will depend on the demographic and
spatial dynamics of the pest species within the target zone (Edgington and Alphey
2018; Wilkins et al. 2018) and its connectivity to surrounding nontarget populations. Because measuring this risk in the field is in itself risky, important preliminary steps are to understand the ecological risk landscape in silico using simulations
and experimental data collected in a virtual environment under stringent confinement conditions (Abbasi 2016; Akbari et al. 2015).
Another promising approach capitalizes on the precise genome editing afforded
by CRISPR-Cas systems to target locally unique sequences that are fixed in the
population of interest (i.e., locally fixed alleles, LFA) but absent (or at low frequency) in nontarget populations (Campbell et al. 2019). Evidence suggests that a
single nucleotide change in the proto-spacer adjacent motif (PAM) associated with
a sgRNA target site can be sufficient to preclude endonuclease binding (Hsu et al.
2013). Thus, population specificity might be accomplished through designing
sgRNA that bind genomic regions harboring polymorphisms that form a functional
PAM site in the target populations, but not in nontarget populations. Recent modeling efforts (Sudweeks et al. 2019) demonstrate that such an approach can effectively
achieve localized population suppression under a variety of scenarios. Interestingly,
this work suggests that escape and interbreeding of gene-drive-bearing individuals
out of the treatment area are likely to result in only transient suppression of nontarget populations, even when the “susceptible” (i.e., target) allele is present at high
frequencies. This phenomenon is explained by the presence of “resistance” alleles
(i.e., naturally occurring genetic variants that preclude gene drive homing) in nontarget populations that will be rapidly driven to high frequencies as a result of selection against drive-bearing individuals, subject to the assumptions of the model. This
finding also emphasizes the critical importance of thorough population genetic
evaluation of the target population prior to sgRNA design to identify sequences that
are locally invariant, as even a low level of polymorphism would reduce effectiveness of gene-drive-mediated population suppression. Likewise, both recent theoretical (Unckless et al. 2017) and empirical studies (Champer et al. 2017) suggest that
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resistant alleles will inevitably arise spontaneously within populations from de novo
mutations in the target site or by the gene drive itself as a consequence of errors in
the cleavage repair process (e.g., NHEJ). One proposed solution to the evolution of
resistance to gene drives is the design of drive systems with multiplexed sgRNA
(Cong et al. 2013; Champer et al. 2018), that is, multiple sgRNA that each targets
adjacent locally fixed alleles, wherein there is a low likelihood of resistance arising
simultaneously in all targets. Indeed, evidence from modeling efforts suggests that
multiplexed sgRNA is likely to be necessary for population suppression, even under
low levels of NHEJ (Prowse et al. 2017).
The feasibility of the LFA strategy for gene drive containment in the context of
vertebrate pest management will depend critically on several aspects of the population structure and ecological setting. As gene drive effectiveness will be diminished
by the influx of resistant individuals, relatively isolated populations with low levels
of gene flow to nontarget populations, such as oceanic islands, would provide ideal
settings. Small populations of introduced species, which are often founded by a
small number of individuals, are also expected to harbor reduced allelic diversity,
thereby providing a greater number of potential locally fixed allele targets (Morgan
et al. 2018). Overall, it is clear that the success of the LFA approach will depend on
rigorous population genetic survey of allelic variation within the target population
prior to any action.

Impacts and Effectiveness
The most straightforward measure of effectiveness of a pest control technique is to
evaluate how rapidly it reduces the target pest population. However, determining the
effects of control on the resources being protected relative to the effort invested is
critical for choosing a technique with optimal effectiveness (Hone et al. 2017). Yet
this “effort-outcomes relationship” is rarely reported or understood in vertebrate
pest management (Hone et al. 2018). The effort-outcomes relationship not only
highlights how much effort is needed for a desired outcome but also can reveal
which techniques are optimal. It provides additional information over effectiveness
alone for choosing between techniques because there may be multiple techniques
with the same outcome but with drastically different effort levels. For GM organisms, once a technology is ready for application, there is potential for a much lower
application cost than traditional methods (Herman et al. 2019), leading to a more
favorable effort-outcome level relative to other techniques. Appropriately defining
the dimensions of “effort” and “outcomes” in these comparisons is not straightforward, however, and is worthy of much consideration. For example, over what time
scale do we measure outcomes? There may be downstream effects such as increased
crop yield per hectare such that less land must be farmed to protect food security
(Herman et al. 2019). This type of higher efficiency could also lead to lower farming
effort over time, thus affecting a component of management effort (Herman et al.
2019). Lastly, the measure of effectiveness needs to be defined based on the
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management objective. For example, if we define our objective as maximum agricultural sustainability with the smallest ecological footprint, then the optimal technique, or measure of effectiveness, might be different than if we define our objective
simply as maximum crop yield.
Another important component of outcomes is “side effects” or “impacts” of a
control method. Impacts of GM organisms could be beneficial such as reduced carbon emissions (Herman et al. 2019) or reduced health hazards from chemical exposure. Alternatively, GM methods for pest control could alter the population genetics
of an entire species, potentially causing unforeseen impacts on ecosystem function
and stability. Defining and quantifying impacts are as complicated as defining effectiveness and require a systematic decision framework for risk assessment involving
multiple stakeholders (Sanvido et al. 2012).

Regulatory Framework in the United States
A new era of genetic modification began in the 1970s with the generation of a new
plasmid from DNA segments of two distinct plasmid species that was inserted into
a bacterium (Escherichia coli) (Cohen et al. 1973). Questions soon arose regarding
whether products derived from the new genetically modified organisms (GMOs)
would pose greater risks than those products achieved through traditional techniques and whether the regulatory mechanisms were sufficient evaluate safety.
The distribution and use of almost all chemical and biological wildlife damage
control products used to protect agriculture or to control invasive species are regulated under a set of US federal statutes under the jurisdiction of one or more federal
regulatory agencies. The three agencies that have regulatory authority over biotechnology products in the United States are the Food and Drug Administration (FDA),
the Environmental Protection Agency (EPA), and the United States Department of
Agriculture (USDA). These regulatory agencies have oversight of a broad spectrum
of products, including GMOs, and subscribe to risk-based assessments to ensure
human and environmental health. In some instances, the agency responsible for the
regulation of a specific product is uncertain and requires a multiagency conference
and decision as to the most appropriate agency or agencies best suited to provide
regulatory oversight. Regulatory agencies sometimes have overlapping jurisdictions
for a single product. Both of these situations may cause confusion and frustration
for both the public and the regulated community and lead to a lack of confidence in
the processes.
In an effort to stem these concerns, the US White House Office of Science and
Technology Policy (OSTP) formed a workgroup in 1984 to assess the existing regulatory mechanisms for their capability to ensure safety while also fostering a supportive environment for technological development of new biotechnology products.
The OSTP released the “Coordinated Framework for Regulation of Biotechnology”
in 1986 (OSTP 1986). The Coordinated Framework concluded that the existing
laws address most health and safety regulatory processes for biotechnology
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products. Further, the existing laws provide immediate regulatory oversight for the
biotechnology industry, and the implementation of new laws would create uncertainty disruptive to the advancement of new technologies and thus be
counterproductive.
The Coordinated Framework was updated in 1992 to explain the federal regulatory agencies’ oversight roles and responsibilities as provided by statute, describe a
science-based risk assessment process for oversight of biotechnology products
released into the environment, and reaffirm that the regulatory oversight will focus
“on the characteristics of the biotechnology product and the environment into which
it is being introduced” and not whether the process employed to create the product
is safe (Bromley 1992).
Federal regulatory agencies were directed by the Executive Office of the President
in 2015 to further clarify their roles and responsibilities and to develop a strategy to
ensure the regulatory processes are adaptable to scientific advances leading to new
types of products. The Emerging Technologies Interagency Policy Coordination
Committee Biotechnology Working Group was formed to develop the strategy and
update the Coordinated Framework. The result was the National Strategy for
Modernizing the Regulatory System for Biotechnology Products was released in
2016 (OSTP 2019). The Strategy’s priorities are to increase transparency, increase
predictability and efficiency, and support the science that underpins the regulatory
system. The goals of the updated Coordinated Framework, issued in 2017, were to
increase public understanding and confidence in the regulatory system and “to prevent unnecessary barriers to innovation and competitiveness.” The statutory authorities and roles of the FDA, EPA, and USDA were again reaffirmed (OSTP 2016, 2017).
The FDA has broad statutory authority under the Federal Food, Drug, and
Cosmetic Act (FDCA) over human food and animal feed including pesticide residues, drugs, cosmetics, and biological products. Genetically engineered animals are
regulated under the drug provisions with exceptions including GMO mosquitoes
intended only for mosquito population control. Drugs are defined in statue as “articles (other than food) intended to affect the structure or any function of the body of
man or other animals” (21 CFR § 321).
Early research in vertebrate species focused on the genetic modification of
domestic animals for the production of human drugs. This precedent formed a natural fit for FDA to regulate all genetically engineered animals irrespective of the
genetic alteration. Other genetically engineered organisms regulated under the
FDCA are human and animal foods derived from non-pesticidal GM plants and
human drugs, biological products, and medical devices derived from GE sources. It
is important to note that FDA regulates the genetic construct and not the animal itself.
All pesticides registered, distributed, and used in the United States are regulated
by EPA under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA).
The EPA definition of a pesticide is “any substance (or group of structurally similar
substances if specified by the Agency) that will prevent, destroy, repel or mitigate
any pest, or that functions as a plant regulator, desiccant, or defoliant…” with specific exceptions provided in 40 CFR § 174.3. Under this authority, EPA regulates
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three major classes of pesticides: conventional, microbial, and biopesticides.
Historically, all pesticides were regulated under a single framework. In time, microbial pesticides and biopesticides were split from conventional pesticides, and each
is now regulated under their own respective requirements more suited to their formulations and uses. GMO pesticides include microbes modified to produce a pesticide, crops tolerant to specific herbicides, plant-incorporated protectants (PIP) that
express pesticidal properties, and most recently mosquitoes genetically engineered
to control a pest. In addition to FIFRA, EPA has authority to regulate the allowable
level of pesticide residues allowed in food and feed under the FDCA.
Several agencies within the USDA exercise authority over certain plants and
animals, food and feed, and products intended to mitigate plant and animal disease,
all of which may include biotechnology products. The USDA’s statutory authority
is provided by the Plant Protection Act (PPA, Public Law 106–224), Animal Health
Protection Act (AHPA, Pub. L. 107–171, 116 Stat. 494, 7 U.S.C. 8301), and the
Virus-Serum-Toxin Act (VSTA, 21 USC 151–159). The USDA Animal and Plant
Health Inspection Service (APHIS) has regulatory oversight under PPA and AHPA
over biotechnology products that are considered plant pests or noxious weeds and
livestock pests including but not limited to those that cause disease. The USDA
Center for Veterinary Biologics has regulatory authority under VSTA over veterinary biological products to prevent, diagnose, and treat disease in animals. Several
other statutes are administered by the USDA Food Safety and Inspection
Service (FSIS).
In summary, primary regulatory authority is determined by how the various federal laws define the different classes of products, which is based on their intended
use, composition, route of administration, and mechanism of action rather than the
technology used to create them (Ruell et al. 2016; OSTP 2017; Wozniak 2018).
These regulatory laws also encompass completely novel biotechnologies or novel
uses of existing technologies that alter the structure or function of organisms, unless
they have already been specifically exempted by law or agency rulemaking (OSTP
2017; Wozniak 2018). All three of the federal agencies have shared roles and
responsibilities that require coordination (Table 1). In particular, the USDA and
FDA often coordinate due to overlapping jurisdiction, but development of these
newer technologies emphasizes the challenges for regulatory agencies to adapt
existing regulatory frameworks to this changing technological landscape.
The different agencies charged with regulating these products have developed
different sets of standards and requirements based on the particularities of the
underlying laws they are charged with implementing (Ruell et al. 2016; OSTP
2017). Therefore, early knowledge of a potential product’s regulatory situation is
crucial for researchers when determining the feasibility of gaining authorization for
the product and in order to comply with and meet the relevant regulatory requirements during the research and development phase. Any field testing of experimental
products usually requires some form of authorization from the agency with primary
regulatory jurisdiction. In addition, notification and authorization are also often
required prior to importing, exporting, or interstate transporting of experimental
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Table 1 Summary of pesticide category, claims, characteristics, and application method
Product category
Vertebrate animal
with intentionally
altered genomic
DNA

Product claim
Population control/
eradication of a target
vertebrate pest through
reproduction of the edited
animal with wild
individuals to produce
predominantly male,
infertile, inviable, or
reduced fitness offspring

Invertebrate
animal with
intentionally
altered genomic
DNA

Repel/kill/contracept a
target vertebrate pest

Modified
bacterium or
fungus

Kill a target vertebrate pest

Product characteristics
Derived from
vertebrate pest species
Edited to sire
predominantly male,
infertile, or inviable
offspring
With or without gene
drive
Vertebrate pest is native
or invasive
Not a pest under the
Livestock Health
Protection Act (LHPA)a
Edited to produce the
product (a substance)
Product is not
harvested, but rather is
applied as a release of
the live invertebrate
Not a pest under the
LHPAa
Not a plant pest under
the Plant Protection Act
(PPA)a

Application method
Environmental
release of live
individuals to breed
with target vertebrate
pest

Environmental
release of the live
invertebrates to be
consumed by target
vertebrate pest (oral
application)

Oral application of
dead invertebrate
Edited to produce the Oral, dermal,
product (a substance) inhalation
application to target
Product is harvested
from and applied apart vertebrate pest
from the invertebrate
itself
Not a pest under the
LHPAa
Not a plant pest under
the PPAa
Oral, dermal,
Designed to cause
inhalation
disease (target-
application to target
specific) in a
vertebrate pest
vertebrate pest
Not a pest under the
LHPAa
Not a plant pest under
the PPAa
(continued)
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Table 1 (continued)
Product category Product claim
Substance causing Kill or contracept a target
RNA interference vertebrate pest

Nanomachines
with pesticides

Kill or contracept a target
vertebrate pest

Substance causing
change in sensory
organ perception
or ill feeling

Repel a target vertebrate
pest from the food, forage,
or prey through aversive
conditioning

Device combined
with a substance
that causes
infertility

Contracept a target
vertebrate pest

Product characteristics
Designed to cause
degradation of mRNA
and prevent translation
of a specific protein
(target-specific) within
the target vertebrate
pest
Toxicant or
contraceptive
combined with
nanorobotics (delivery
device)
Causes unpleasant
sensory feedback or
function, or causes
sickness when
combined with
normally attractive
foods, forage, or prey
Contraceptive

Application method
Oral, dermal,
inhalation
application to target
vertebrate pest

Oral or inhalation
application to target
vertebrate pest
Nanorobotics used to
deliver pesticide to
target organ
Oral, dermal,
inhalation
application to target
vertebrate pest

Insertion into a
female reproductive
body cavity

Would not fall under USDA APHIS regulatory authority

a

products. Conventional wildlife damage products with clear regulatory precedents
are relatively easy to classify under the different regulatory jurisdictions.

Regulatory Framework: Gene Silencing Using RNAi
The regulatory framework for the new generation of RNAi-based pesticides would
likely follow the general guidelines for biopesticides, which are modified from conventional pesticides (OSTP 1986). If applied to growing crops, the FDA ensures the
food from crops containing RNAi is as safe as its conventional counterpart. The
USDA ensures there is no risk to agriculture from the use of RNAi. The EPA ensures
that the product can perform its intended function with a reasonable certainty of no
harm to people from dietary and residential exposure and no unreasonable risks to
the environment.
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Regulatory Framework: Gene Editing
Regulatory jurisdiction of novel GM products for wildlife damage control can be
more difficult to classify and may require prolonged consultation between the regulatory agencies themselves before a final designation is made. As an example, products consisting of microorganisms or invertebrates, whether unmodified or modified
(including GM), which are used to change the structure or function of animals, have
been on the market for some time, and, for the most part, are now distributed among
the regulatory agencies (Wozniak et al. 2012; Ruell et al. 2016; FDA CVM 2017a,
b; OSTP 2017; EPA OPP 2018; Wozniak 2018). They are regulated by USDA based
on whether they qualify as a pest to livestock as defined by the AHPA or as a veterinary biologic as defined by VSTA. They are regulated by EPA if they or their
byproducts are used as pesticides against pests as defined by FIFRA. Any other
product that uses microorganisms with the intent to directly change the structure or
function of animals is regulated by FDA.
In contrast, products consisting of vertebrate animals fall into much different
regulatory classifications that are not as clear cut. Non-GM vertebrate animals
released to control a pest species, aka biological control agents (e.g., the release of
mongooses to control rats on islands), do not qualify as products requiring authorization under the FDCA and have been exempt from the registration requirements of
FIFRA by EPA (40 C.F.R. § 152.20(a)(3)). However, EPA has left the door open to
revoke this exemption for any biological control agent it considers to be inadequately regulated by other federal agencies (40 C.F.R. § 152.20(a)(2)). In contrast,
GM vertebrate animals do fall under the provisions of the FDCA, or more accurately, the intentionally altered genomic DNA within the GM animal becomes the
regulated article because it changes the structure of function of the animal for an
intended purpose (FDA CVM 2015, 2017a; OSTP 2017). This intentionally altered
genomic DNA in a GM vertebrate animal is not currently classified as a regulated
article under the AHPA, VSTA, or FIFRA, although a substance produced by a GM
vertebrate animal could be regulated separately by another agency if it meets their
definition of a regulated article (FDA CVM 2015; Ruell et al. 2016; FDA CVM
2017a). Several GM vertebrate animal products have made their way through part
of or the whole approval process with FDA to date (e.g., GE salmon, chickens,
goats), although none so far were designed for use in wildlife damage control or
pest management (EPA OPP 2018).
It is possible that the Congress or FDA and EPA may one day determine that
certain GM vertebrate animals intended for population control of vertebrate pests
will be classified as pesticides and regulated under FIFRA instead of under the provisions of the FDCA, similar to GM mosquitos intended solely for mosquito population control (FDA CVM 2017b). The two agencies have started working together
to determine statutory authority over these types of GM animal products for pest
management on the horizon, but it is unclear whether this will change their regulatory jurisdiction in the near future (EPA OPP 2018). Until alternative guidance is
issued by FDA and EPA, the primary regulatory authority over all GM vertebrate
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animals will remain FDA (FDA CVM 2017a; OSTP 2017). FDA will work closely
with EPA and other federal regulatory agencies charged with implementing environmental laws before authorizing any experimental field use or eventual approval
of these novel products (FDA CVM 2017a). FDA recommends that product developers contact them early in the development phase of product development of GM
vertebrates (FDA CVM 2017a).
There can be significant disadvantages for developers submitting the first product of its kind to a regulatory agency that result in unforeseen delays and costs prior
to authorization. Many agencies, including EPA, will convene Scientific Advisory
Panels at the expense of the applicant to help them determine how to appropriately
evaluate the risk of the novel product type and the appropriate set of regulatory data
they will require from the registrant prior to authorization (EPA OPP 2018). Once
the agency’s risk assessment process has been determined, study guidelines must
then be developed and finalized for each data requirement. However, they will not
usually initiate these processes until after they receive an application or information
on an actual product, because these processes take considerable time and resources.
There is also the potential that a novel product could change regulatory hands
midstream in the regulatory authorization process or even after a product has been
authorized by an agency, like what happened with GE mosquitos used for mosquito
population control, and this can pose additional difficulties and added costs for the
applicant. For example, data that were collected or contracted for one authorization
process may not be directly applicable or adequate for the next. The manufacturing
and National Environmental Policy Act requirements for the product also differ
depending on the agency and regulatory statute. Some regulatory statutes allow
government agencies to take products through the full authorization process, and
some require a private or nonprofit entity to be the applicant. Thus, last minute
changes to the regulatory jurisdiction of a product can result in considerable challenges for the product developer in predicting the practicality and use timeline for
novel products such as GM vertebrate animals used in animal damage control.

Translational Product Development
Translational product development can be thought of as a pipeline or continuum as
an idea moves from research and development to fully implemented product or
technique. Figure 1 graphically illustrates that pipeline for a regulated product.
Early in the process, pilot and confirmatory development steps are undertaken to
provide the information needed to assess the product development costs, market
potential, and ultimately the viability of the product. Early in the product development pipeline, decisions are normally made regarding protecting intellectual property and the need to form development and commercialization partnerships. In the
case of regulated products such as a pesticide, biologic, vaccine, or drug, a realistic
assessment must be made as to the cost of regulatory studies and the time it will take
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Fig. 1 Conceptual product development pipeline for regulated products developed in a federal
laboratory

to obtain a product authorization. All of these aspects inform decisions in advancing
development efforts.
As this chapter outlines, developments in our ability to manipulate or target the
genetic code of an organism have opened up an entirely new world for product
development. The application of genetic tools appears to be boundless in advancing
medical, agricultural, and conservation goals. At the heart of biotechnology product
development is the decision and ability to protect the intellectual property. To illustrate this, two potential biotech techniques or tools that will prove useful in agricultural production and conservation will be briefly presented. Both of these
technologies, gene silencing and gene editing, share the same general product
development pipeline but have significant variations along that path.

Intellectual Property Protection
At the heart of translational product development is technology transfer and, if
appropriate, protection of intellectual property. There are many definitions of technology transfer, but in essence, it is the process by which technology or knowledge
developed in one place or for one purpose is applied in and used in another place
(FLC 2006). Two conditions are responsible for initiating or accomplishing technology transfer, a technology is created and pushed into practice, or some identified
need creates the opportunity for a new technology. Regardless of what initiated the
product development effort, the successful transfer from development to practice is
the goal. An idea, technique, or tool is underutilized until it is put into practice.
Patent protection from the US Patent and Trademark Office or other international
patent authorities can be a major driver of technology transfer. Patent protection
allows the patent owner to exclusively pursue the development of the patented tool
or technique or to license the rights to practice the patent to another entity, typically
for a fee. As advances in genetic technologies allowed us to sequence genomes and
identify specific genome sequences that were responsible for specific physiological
functions, scientists and businesses sought patent protection of gene sequences they
had identified in the hopes of capitalizing on those discoveries and future
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applications of that knowledge. The idea of patenting naturally occurring genetic
code quickly became a hotly debated topic. Many found the idea of “owning” the
knowledge of a person’s genetic code unethical. Despite the debate, 4300 patents
were issued for the human genome alone prior to 2013. In 2012, the US Supreme
Court ruled that DNA in its natural form cannot be patented; however, DNA manipulated in a lab is eligible to be patented because DNA sequences altered by humans
are not found in nature (NIH 2017, 2019; SCOTUS 2013). While this ruling closed
the door on capitalizing on a person’s genetic code, it defined what was allowed to
be patented and provides the guidance for those seeking intellectual property protection for intentionally modified genetic tools.

Intellectual Property: Gene Silencing Using RNAi
As previously described, the ability to intentionally prevent or inhibit normal RNA
translation has profound impacts on an organism’s physiological function and has
enormous potential to be utilized in human medicine, agricultural production, and
many other beneficial areas. An example of a gene-silencing tool for agricultural
protection is the development of new pest management tools, such as active ingredients used in pesticides. Typical pesticides function by disrupting a biochemical
mechanism critical to life. Common biochemical mechanisms include, but are not
limited to, cholinesterase inhibitors, which function by inhibiting nerve impulse
transmission across synaptic junctions, and other pesticides disrupt the production
of ATP by impacting enzyme production critical to normal Krebs cycle functions.
Gene silencing could target similar critical functions but at the genetic level, by
introducing engineered strands of RNA into the cell, which disrupt translation or
transcription processes.
Taking advantage of an organism’s unique genetic code could potentially lead to
the development of species-specific, humane pesticides with reduced risk of unintended environmental or human health consequences. Such an approach could revolutionize pest management, leading to dramatic advances in agricultural and human
health protection, and associated economic benefits to protected resources in addition to significant economic benefits to companies advancing these technologies.
For these reasons, there will be a great desire to protect the intellectual property
behind the technologies. Patenting is available for gene-silencing tools because the
patented technology would not be based on the native genetic code or an organism,
but rather on the man-made genetic sequences introduced into cells which disrupt
normal RNA translation or transcription processes. In the case of pest management,
most of these types of products would be regulated as pesticides by the US
EPA. Consequently, there is clear understanding of the regulatory path these products would face. Even though this line of product development is high risk, having
regulatory clarity paves the way for clear product development efforts.
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Intellectual Property: Gene Editing
Directly editing the genetic sequence of an organism has the potential for significant
contributions to agriculture, human health, and natural resource protection. As
described above, the discovery of native CRISPR-Cas systems and the knowledge
of how to utilize these systems to make specific gene edits have revolutionized our
ability to produce single-generation designer organisms. Current lines of research
are focused on developing gene-edited organisms that pass the desired trait to a high
proportion of their offspring in a way that it is active in subsequent generations,
known as “gene drive” systems. Driving a trait through a population has enormous
social implications and elicits very controversial discussions, especially when it
could be applied to natural resource conservation issues. Despite those important
discussions, work will continue to develop applications of gene-edited and gene
drive organisms because associated economic benefits are presumed to be high. If
the resulting products include unnatural genetic sequences in an organism, there is
a potential for seeking patent protection.
The decision to protect intellectual property is only one step of the technology
transfer pipeline. The ultimate proof that product development efforts were successful is seeing that technology adopted somewhere in society. However, an important
consideration is that the ultimate landing place of a technology may not be what the
original researchers and product developers intended.

Future Directions
Wildlife damage conflicts continue to increase as the world’s population increases.
Generally speaking, mitigation of a conflict implies an active management or control program. Typically, conflicts manifest themselves as invasive species and disease impacts on native ecosystems and damage caused by wildlife to commodities
of value to humans (e.g., agriculture, property, health, safety, property). Managers
must weigh the options available to them to mitigate the conflict in terms of economics, effectiveness, environmental effects, and humaneness, all within a social
framework. A question becomes whether today’s technologies will be well suited to
constraints and problems we may face into the future. For example, will today’s
reliance on chemical pesticides continue into the future, and if not, what mitigation
tools and strategies will replace these methods? Like many new technologies that
were introduced in the past, there is great promise and apprehension about these
new genetically based methods in terms of development and use. Herein, we
reviewed the context, opportunities, and challenges of genetically based biopesticides and provided some social, technical, and regulatory practicalities in research
and development for technologies such as gene silencing and gene drives. The
encouraging news is that the scope and depth of discussions are vigorous and
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inclusive (e.g., scientists, ethicists, managers, regulators, the public, and policy
makers), all of which bodes well for informed decision processes.
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